Concepedia

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin

Roberto Latini, Gianni Tognoni, Aldo P. Maggioni, MariaGrazia Franzosi, Eugenio Santoro, Colin Baigent, Zheng-Ming Chen, Rory Collins, Richard Peto, Peter Sleight,

Journal of the American College of Cardiology · 2000 · 167 citations · 27 references

DOI

Concepts

References

27

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction

Marc A. Pfeffer, Eugene Braunwald, Lemuel A. Moyé et al. · New England Journal of Medicine · 1992 · 6K citations

, , +13

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

, , +10

Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

R B Sleight, Peter Sleight, Sarah Parish et al. · PubMed · 1988 · 2.9K citations

, , +9

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure

D G Julian, A J Moss, Gordon Murray et al. · The Lancet · 1993 · 1.9K citations

, , +12

ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction

The Lancet · 1995 · 1.8K citations

, , +12